You are here

Interviews

10 Emprenedores

“Many more role models are needed.” Women's presence in the Catalan biomedical ecosystem

There are around 100 startups in the BioRegion of Catalonia led and/or founded by women, representing such diverse fields as biotechnology, medical technologies, digital health and investment, among others. To commemorate the International Day of Women and Girls in Science on February 11, we have interviewed ten women entrepreneurs from the BioRegion who have launched a company within the past three years.

Teleworking

Remote working in the BioRegion: a new reality that is here to stay?

Last March, the SARS-CoV-2 pandemic put mobility and social life on hold in most of the world, however in biotech and healthcare, things didn’t stop at all. It was just the opposite, in fact, with activity ramping up. But the pandemic has forced the sector to turn to new ways of working and, in some cases, seem they’re here to stay. 

e-pitch session

How to put together the perfect pitch during a pandemic

At the time of this pandemic that we live in, in which meetings and presentations are made virtually, pitch preparation is key. We detail some aspects to take into account when presenting your idea to worldwide investors and future clients.

Top 10 tips from entrepreneurs in the BioRegion

More than 50 interviews with entrepreneurs and 5 years of Startup Generation make for many insights, anecdotes and experiences. We have compiled some of them in this top ten so that they can serve you as inspiration.

Clara Campàs (Asabys Partners): “Society’s growing interest in science due to Covid-19 could boost investment in healthcare”

Clara Campàs, partner and co-founder of specialized venture capital fund Asabys Partners, analyzes how the global Covid-19 crisis is affecting the sector and is optimistic about the future of investment in healthcare.

Joël Jean-Mairet (Ysios Capital): “The Covid-19 crisis has to remind us of the need to innovate in the life sciences”

Joël Jean-Mairet, managing partner of Ysios Capital, explained how he sees this crisis from the perspective of a venture capital fund and warns that continued investment in healthcare innovation is more necessary than ever.

Marta-Gaia Zanchi (Nina Capital): “This year we will see lower investment in health technology concentrated in fewer deals”

Dr. Marta-Gaia Zanchi, founder and managing partner of Nina Capital, explains how the Covid-19 pandemic could affect investment in digital health and medical technology.

Montserrat Vendrell (Alta Life Sciences): "Covid-19 is opening a lot of doors for business and investment opportunities in the healthcare sector”

Montserrat Vendrell, partner in the Alta Life Sciences investment fund, explains how investors are experiencing the Covid-19 pandemic and highlights one of the few positives that may come out of this crisis: new opportunities in the healthcare sector.

Lluís Pareras (Invivo Ventures): “Stopping now would be a mistake”

Lluís Pareras, founding partner of the new fund Invivo Ventures, is optimistic about the future of the life sciences sector and warns that companies need to keep working at a good pace these months so they don’t lose inertia.

Jordi Naval
26.09.2018

Jordi Naval

CEO of Biocat

Jordi Naval (Barcelona, ​​1969) holds a degree in Pharmacy from the University of Barcelona (UB) and a degree in Biochemistry from the Autonomous University of Barcelona (UAB). Over the past 18 years Naval has been involved in the creation of several start-ups (Infociencia, Anaxomics, Enemce Pharma, Genocosmetics Lab and Aelix Therapeutics) and was Director of the Bosch i Gimpera Foundation between 2015 and 2017 and President of the Escola d'Emprendedors Foundation from 2010 to 2017. He was appointed new CEO of Biocat last July.